Harvard Apparatus Regenerative Technology, Inc. (HRGN) Total liabilities 2016–2025
Harvard Apparatus Regenerative Technology, Inc. (HRGN) total liabilities at each fiscal year-end, per SEC filings.
$1.6MFY2025 · since FY2016: $2.8M → $1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6M | +32.8% |
| FY2024 | $1.2M | +26.0% |
| FY2023 | $968,000 | — |
| FY2021 | $4.9M | +414.7% |
| FY2020 | $951,000 | +5.3% |
| FY2019 | $903,000 | +36.4% |
| FY2018 | $662,000 | -59.2% |
| FY2017 | $1.6M | -41.6% |
| FY2016 | $2.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More HRGN financial trends
HRGN RevenueHRGN Net incomeHRGN Net marginHRGN Gross profitHRGN Gross marginHRGN Operating incomeHRGN Operating marginHRGN Operating cash flowHRGN Free cash flowHRGN Capital expendituresHRGN Return on equityHRGN Stock buybacksHRGN Dividends paidHRGN Total assetsHRGN Shareholders’ equityHRGN overview →